BETA BIONICS INC (BBNX)
Health Care · Diabetes management devices / artificial pancreas systems · NASDAQ
Beta Bionics develops automated insulin delivery and glucose management systems for people with diabetes.
What BETA BIONICS INC does
Beta Bionics develops advanced diabetes management devices and systems, with a focus on automated insulin delivery solutions. The company commercializes products through a multi-channel distribution strategy targeting both direct-to-consumer and healthcare provider channels. The company is experiencing strong revenue growth of over 56% year-over-year and is working to establish reimbursement pathways and expand market reach across the United States.
Themes: ["Diabetes / glucose management","Automated insulin delivery","Medical devices","Digital health","Chronic disease management"]
Fundamentals
- Price$16.43 as of 2026-07-09 close
- Market cap$721M as of 2026-07-10
- 1-year return+21.2% as of 2026-07-09 close
- Net margin-60.3% as of 2026-07-10
- Gross margin+57.1% as of 2026-07-10
- ROE-23.0% as of 2026-07-10
- Debt / equity0.00 as of 2026-07-10
- Revenue growth (YoY)+56.6% as of 2026-07-10
- Revenue CAGR (3y)+189.1% SEC XBRL
- Beta0.56 as of 2026-07-10
Key risks (from latest filing)
["Regulatory approval risk: Dependence on FDA and international regulatory bodies for product clearance and approval of existing and future products","Reimbursement and market adoption risk: Ability to obtain insurance coverage and achieve market acceptance for automated insulin delivery systems","Manufacturing and supply chain risk: Reliance on third-party suppliers and ability to accurately forecast and manufacture products to meet commercial demand"]
Competitors & peers
- Medtronic (MDT)
- Insulet Corporation (PODD)
- Tandem Diabetes Care (TNDM)
- Ypsomed
- Roche (diabetes care division)
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.